Uncertainty is the new normal in biotech and pharma. At @meetclora, we explore how leaders are shifting to flexible, dynamic talent strategies to stay resilient in a volatile world. Read our latest report on adapting to change: linkedin.com/pulse/meeting-…
Rahul Chaturvedi
@rahulc
Drug and device developer now out to change how we do it with tech @meetclora
2.3K Following 467 Followers 71 Posts
Latest posts 5
Join me on the @Biotech2050Pod podcast with Kristin Yarema, President & CEO of @PoseidaThera. We discuss corporate culture, Allogeneic CAR-T therapies, and bridging the gap between physicians’ visions for medicine and investor priorities.
🔥 Host @rahulc explores bold biotech breakthroughs with Kristin Yarema, President & CEO of @PoseidaThera. From redefining cell therapy to inspiring leadership insights, this is a must-listen on the future of medicine! 🎧 on.soundcloud.com/g8drxxB8BH8N1B… #Biotech2050 #CellTherapyView quoted post on X
Join me on the @Biotech2050Pod podcast with Bharatt Chowrira & @EricElenko of @PureTechH. We dive into their model for tackling big problems, the founding of @KarunaTx, and the benefits of evergreen funding.
Dive into the latest #Biotech2050 episode! Host @rahulc joins Bharatt Chowrira, CEO & @EricElenko, Co-Founder & President of @PureTechH as they share lessons on innovative R&D, tackling challenges, & Karuna Therapeutics' journey. Listen: on.soundcloud.com/qM5bpRmzwU8auR… #Biotech #PodcastView quoted post on X
I spoke with Abe Ceesay, CEO of Rapport Therapeutics, on what it takes to scale talent, lead with a servant mindset, and drive smart risk-taking in biotech. Hear his take on building emotional safety and more.
✨ Ready for the future of precision neuroscience? Abe Ceesay, CEO of Rapport Therapeutics, & #Biotech2050 host @rahulc dive into treatments for neurological disorders like focal epilepsy. Don’t miss these insights! Listen: on.soundcloud.com/bfTa3VLAE46yPK…View quoted post on X
#PrecisionNeuroscience #biotech
Had a great conversation with @dave_bearss, CEO of @Halia_Tx, about the founding of the company, how their initial focus on the APOE4 gene led them to focus on inflammation, and their non-traditional financing strategy for clinical stage assets. Tune in.
Don't miss this #Biotech2050 episode! @dave_bearss, CoFounder & CEO of @Halia_Tx, shares how they're leading the fight against Alzheimer’s w/ pioneering genetic discoveries & innovative therapies. Hosted by @rahulc Listen: on.soundcloud.com/Jn2APTDkoNxUye…View quoted post on X
#BiotechPodcast #AlzheimersCure